CE and HPLC applications for rAAV characterisation
Posted 17th January 2020 by Joshua Sewell
Despite recent advances in the gene therapy field, significant challenges lie ahead for the consistent manufacturing and release of these medicines. Analytical methods and automation need to keep pace as more medicines move towards the market and more quality control resources are required. Well-developed methods on robust platforms will be crucial to ensure the quality of these novel medicines for the doctors and patients who need them.
Improving the selection of candidate CD8+ T cell epitopes for immunotherapy
Posted 6th January 2020 by Joshua Sewell
Alongside the talks at our conferences, the poster presentations are a huge part of the knowledge sharing that takes place. We’re thrilled to be able to take a closer look at this poster from the Research & Technology Series, presented by Wim van Esch and the team at Sanquin.
Inspirata and Cirdan Announce New Technical Partnership at the Digital Pathology & AI Congress
Posted 18th December 2019 by Joshua Sewell
At the 6th Digital Pathology & AI Congress, Inspirata and Cirdan announced their new technical partnership designed to empower NHS clinical laboratories to accelerate their use of digital pathology.
Ireland and the Future of Biopharmaceutical Manufacturing
Posted 16th December 2019 by Liv Sewell
Ahead of the 3rd Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress in Dublin, we consider how Ireland is uniquely positioned to play a significant role in the next generation of biopharmaceutical manufacturing and delivery of life changing medicines.
The Future is Bright for Microbiome Metabolites and Drugs Derived From Probiotics
Posted 9th December 2019 by Joshua Sewell
Some of the claims made about Probiotics can be hard to believe, and often even harder to reliably prove. However, the science surrounding the development of these products is exciting, and some of the more extraordinary claims can be quantified.
Here a few examples from some of the presentations at the Microbiome & Prebiotics Series: USA:
The Future is Bright for Probiotics
Posted 2nd December 2019 by Joshua Sewell
I am extremely sceptical of all claims about probiotics. For the last 10 years of running Probiotics.org, companies have been sending me questionable products with extraordinarily impossible to believe claims.
But, after Global Engage’s 4th Probiotic & Prebiotics Congress, here’s what I strongly believe:
3 Ways Single-Cell Sequencing and AI are Transforming Kidney Transplantation
Posted 27th November 2019 by Liv Sewell
Transplantation is now a successful therapy for end-stage renal disease (ESRD). The first successful kidney transplantation happened in Boston in 1954 and the procedure is now routine clinical practice in more than 80 countries worldwide.
Ishita Moghe and Kim Solez outline some of the major strides taken in kidney pathology and transplantation through the use of scRNA-seq and Artificial Intelligence (AI).
Slides from the 4th Medicinal Chemistry & Protein Degradation Summit
Posted 26th November 2019 by Joshua Sewell
The 4th Medicinal Chemistry & Protein Degradation Summit provided two days of fascinating topics and case studies about AI-assisted lead optimisation, DNA encoded libraries and the use of data and informatics in drug-discovery. We have made the following presentation slides available from Greg Makara, Paul Colbon and Yugal Sharma.
